Evidence map›Paper›PMID 33429294›Full record

ArticleDrug and alcohol dependence2021

A preliminary examination of the multiple dimensions of opioid craving.

Cecilia L Bergeria, Justin C Strickland, Andrew S Huhn, Eric C Strain, Kelly E Dunn

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cecilia L BergeriaDepartment of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine, Baltimore, MD, United States. Electronic address: cberge21@jhmi.edu.
Justin C StricklandDepartment of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Andrew S HuhnDepartment of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Eric C StrainDepartment of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine, Baltimore, MD, United States.
Kelly E DunnDepartment of Psychiatry and Behavioral Sciences Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Funding

HUMAN BEHAVIORAL PHARMACOLOGY OF SUBSTANCE ABUSET32DA007209 · NIDA · JOHNS HOPKINS UNIVERSITY · PI Eric C. Strain, Elise M Weerts · 1985 to 2026
$12.9M
Evaluating a Mechanistically-Supported Pharmacotherapy to Treat Acute and Protracted Opioid WithdrawalR01DA054101 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI Cecilia Bergeria · 2022 to 2026
$3.9M
A118G SNP and OPRM1 Gene Opioid-Mediated Effects in HumansR01DA035246 · NIDA · JOHNS HOPKINS UNIVERSITY · PI DUNN, KELLY E · 2014 to 2018
$3.2M
Developing a Clinical Outcome Assessment for Opioid CravingR21DA054952 · NIDA · JOHNS HOPKINS UNIVERSITY · PI BERGERIA, CECILIA · 2021 to 2022
$450k
NIDA NIH HHS R01 DA035246NIDA NIH HHS R01 DA054101NIDA NIH HHS R21 DA054952NIDA NIH HHS T32 DA007209
6 · The paper itself

Abstract

backgroundAlthough craving is a formal DSM-5 criterion and a commonly reported feature of opioid use disorder (OUD), there is no universally accepted assessment of opioid craving for treatment outcome studies or clinical trials. This mixed-methods study characterized dimensions of opioid craving identified in qualitative responses collected via Amazon Mechanical Turk (AMT).

methodThirty-nine participants completed an online screener on AMT and met inclusion criteria (e.g., > = 18 years old and past 30-day illicit opioid use). These participants completed a series of closed- and open-ended questions about their opioid use and craving, including several commonly-used craving measures. They also rated their preference for how different questions described craving. Responses to the open-ended question "What do you mean when you say you are craving opioids?" were coded according to dimensions in existing opioid craving assessments and other common themes identified in the data.

resultsAmong the 39 participants, 8 different dimensions were identified and coded. Descriptions of craving were most frequently categorized as "Anticipation of Negative Reinforcement" (n = 17/39) and "Interfering Thoughts" (N = 14/39). Individuals with drug use characteristics reflecting greater severity of use were more likely to describe craving as "Interfering Thoughts". Participants may prefer opioid craving questions that included Visual Analog Scale response formats relative to Likert scales.

conclusionsThere is a wide range of dimensions that were used to describe opioid craving and no single unifying dimension was identified. These data suggest opioid craving is a multidimensional construct including dimensions currently not included in common craving assessments.

Indexed as

CravingAdolescentAdultAnalgesics, OpioidDiagnostic and Statistical Manual of Mental DisordersFemaleHumansMaleMiddle AgedOpioid-Related DisordersAnalgesics, OpioidContent validityCravingMixed-methodsOnline crowdsourcingOpioids

Identifiers

PMID33429294
PMCPMC10041947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.